Global Drugs for Traveler's Diarrhea Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Drugs for Traveler's Diarrhea market report explains the definition, types, applications, major countries, and major players of the Drugs for Traveler's Diarrhea market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Prokarium Limited

    • Scandinavian Biopharma

    • GSK

    • Salix Pharmaceuticals

    • Chiesi Farmaceutici

    • Cosmo Pharmaceuticals

    • Nippon Shinyaku

    • Sigmoid Pharma

    By Type:

    • Anti-motility agents

    • Bismuth Subsalicylate (Pepto-Bismol)

    • Antibiotics

    By End-User:

    • Adult

    • Children

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Drugs for Traveler's Diarrhea Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Drugs for Traveler's Diarrhea Outlook to 2028- Original Forecasts

    • 2.2 Drugs for Traveler's Diarrhea Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Drugs for Traveler's Diarrhea Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Drugs for Traveler's Diarrhea Market- Recent Developments

    • 6.1 Drugs for Traveler's Diarrhea Market News and Developments

    • 6.2 Drugs for Traveler's Diarrhea Market Deals Landscape

    7 Drugs for Traveler's Diarrhea Raw Materials and Cost Structure Analysis

    • 7.1 Drugs for Traveler's Diarrhea Key Raw Materials

    • 7.2 Drugs for Traveler's Diarrhea Price Trend of Key Raw Materials

    • 7.3 Drugs for Traveler's Diarrhea Key Suppliers of Raw Materials

    • 7.4 Drugs for Traveler's Diarrhea Market Concentration Rate of Raw Materials

    • 7.5 Drugs for Traveler's Diarrhea Cost Structure Analysis

      • 7.5.1 Drugs for Traveler's Diarrhea Raw Materials Analysis

      • 7.5.2 Drugs for Traveler's Diarrhea Labor Cost Analysis

      • 7.5.3 Drugs for Traveler's Diarrhea Manufacturing Expenses Analysis

    8 Global Drugs for Traveler's Diarrhea Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Drugs for Traveler's Diarrhea Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Drugs for Traveler's Diarrhea Export by Region (Top 10 Countries) (2017-2028)

    9 Global Drugs for Traveler's Diarrhea Market Outlook by Types and Applications to 2022

    • 9.1 Global Drugs for Traveler's Diarrhea Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anti-motility agents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Bismuth Subsalicylate (Pepto-Bismol) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antibiotics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drugs for Traveler's Diarrhea Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Children Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Drugs for Traveler's Diarrhea Market Analysis and Outlook till 2022

    • 10.1 Global Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.2.2 Canada Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.2.3 Mexico Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.2 UK Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.3 Spain Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.4 Belgium Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.5 France Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.6 Italy Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.7 Denmark Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.8 Finland Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.9 Norway Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.10 Sweden Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.11 Poland Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.12 Russia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.3.13 Turkey Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.2 Japan Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.3 India Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.4 South Korea Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.5 Pakistan Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.6 Bangladesh Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.7 Indonesia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.8 Thailand Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.9 Singapore Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.10 Malaysia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.11 Philippines Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.4.12 Vietnam Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.2 Colombia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.3 Chile Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.4 Argentina Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.5 Venezuela Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.6 Peru Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.7 Puerto Rico Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.5.8 Ecuador Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.6.2 Kuwait Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.6.3 Oman Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.6.4 Qatar Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.7.2 South Africa Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.7.3 Egypt Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.7.4 Algeria Drugs for Traveler's Diarrhea Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Drugs for Traveler's Diarrhea Consumption (2017-2022)

      • 10.8.2 New Zealand Drugs for Traveler's Diarrhea Consumption (2017-2022)

    11 Global Drugs for Traveler's Diarrhea Competitive Analysis

    • 11.1 Prokarium Limited

      • 11.1.1 Prokarium Limited Company Details

      • 11.1.2 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Prokarium Limited Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.1.4 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Scandinavian Biopharma

      • 11.2.1 Scandinavian Biopharma Company Details

      • 11.2.2 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.2.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GSK

      • 11.3.1 GSK Company Details

      • 11.3.2 GSK Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GSK Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.3.4 GSK Drugs for Traveler's Diarrhea Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Salix Pharmaceuticals

      • 11.4.1 Salix Pharmaceuticals Company Details

      • 11.4.2 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.4.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Chiesi Farmaceutici

      • 11.5.1 Chiesi Farmaceutici Company Details

      • 11.5.2 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.5.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Cosmo Pharmaceuticals

      • 11.6.1 Cosmo Pharmaceuticals Company Details

      • 11.6.2 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.6.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Nippon Shinyaku

      • 11.7.1 Nippon Shinyaku Company Details

      • 11.7.2 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.7.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Sigmoid Pharma

      • 11.8.1 Sigmoid Pharma Company Details

      • 11.8.2 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Main Business and Markets Served

      • 11.8.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Drugs for Traveler's Diarrhea Market Outlook by Types and Applications to 2028

    • 12.1 Global Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Anti-motility agents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Bismuth Subsalicylate (Pepto-Bismol) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Drugs for Traveler's Diarrhea Market Analysis and Outlook to 2028

    • 13.1 Global Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.2.2 Canada Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.2 UK Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.3 Spain Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.5 France Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.6 Italy Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.8 Finland Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.9 Norway Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.11 Poland Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.12 Russia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.2 Japan Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.3 India Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.3 Chile Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.6 Peru Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.6.3 Oman Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Drugs for Traveler's Diarrhea Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Drugs for Traveler's Diarrhea

    • Figure of Drugs for Traveler's Diarrhea Picture

    • Table Global Drugs for Traveler's Diarrhea Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Drugs for Traveler's Diarrhea Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Anti-motility agents Consumption and Growth Rate (2017-2022)

    • Figure Global Bismuth Subsalicylate (Pepto-Bismol) Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotics Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Table North America Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure United States Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Canada Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Mexico Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table Europe Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure Germany Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure UK Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Spain Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Belgium Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure France Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Italy Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Denmark Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Finland Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Norway Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Sweden Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Poland Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Russia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Turkey Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table APAC Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure China Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Japan Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure India Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Thailand Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Singapore Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Philippines Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table South America Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure Brazil Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Colombia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Chile Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Argentina Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Peru Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table GCC Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure Bahrain Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Oman Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Qatar Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table Africa Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure Nigeria Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure South Africa Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Egypt Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Algeria Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table Oceania Drugs for Traveler's Diarrhea Consumption by Country (2017-2022)

    • Figure Australia Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Drugs for Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Table Prokarium Limited Company Details

    • Table Prokarium Limited Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prokarium Limited Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio

    • Table Scandinavian Biopharma Company Details

    • Table Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Scandinavian Biopharma Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio

    • Table GSK Company Details

    • Table GSK Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table GSK Drugs for Traveler's Diarrhea Product Portfolio

    • Table Salix Pharmaceuticals Company Details

    • Table Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio

    • Table Chiesi Farmaceutici Company Details

    • Table Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Farmaceutici Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio

    • Table Cosmo Pharmaceuticals Company Details

    • Table Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio

    • Table Nippon Shinyaku Company Details

    • Table Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nippon Shinyaku Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio

    • Table Sigmoid Pharma Company Details

    • Table Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigmoid Pharma Drugs for Traveler's Diarrhea Main Business and Markets Served

    • Table Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio

    • Figure Global Anti-motility agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bismuth Subsalicylate (Pepto-Bismol) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Table North America Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure United States Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure Germany Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure China Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure Brazil Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Drugs for Traveler's Diarrhea Consumption Forecast by Country (2022-2028)

    • Figure Australia Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Drugs for Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.